-transparent.png){kind=logo}
Gentamicin sulphate was administered to male Wistar rats by intramuscular injection at varying dosage and for varying periods. At high dosage (50-100 mg/kg/day) gentamicin causes tubular necrosis. At dosages equivalent to that given to man (5 mg/kg/day) obvious degenerative changes are produced. Similar changes are seen in human tubular epithelium and urine deposits of patients treated with gentamicin. There is increased excretion of urinary enzymes proportional to the degree of tubular damage. The importance of these changes in man is stressed.
Related Publications
J M Wellwood, and
D Lovell, and
A E Thompson, and
J R Tighe
October 1983,
Drug intelligence & clinical pharmacy,
J M Wellwood, and
D Lovell, and
A E Thompson, and
J R Tighe
July 1976,
Wiener klinische Wochenschrift,
J M Wellwood, and
D Lovell, and
A E Thompson, and
J R Tighe
January 1974,
Biochemical pharmacology,
J M Wellwood, and
D Lovell, and
A E Thompson, and
J R Tighe
January 2000,
Clinical pharmacology and therapeutics,
J M Wellwood, and
D Lovell, and
A E Thompson, and
J R Tighe
January 1976,
Arzneimittel-Forschung,
J M Wellwood, and
D Lovell, and
A E Thompson, and
J R Tighe
March 2004,
Pediatric nephrology (Berlin, Germany),
J M Wellwood, and
D Lovell, and
A E Thompson, and
J R Tighe
January 1995,
Toxicology letters,
J M Wellwood, and
D Lovell, and
A E Thompson, and
J R Tighe
May 1972,
British medical journal,
J M Wellwood, and
D Lovell, and
A E Thompson, and
J R Tighe
January 1979,
Clinica chimica acta; international journal of clinical chemistry,
J M Wellwood, and
D Lovell, and
A E Thompson, and
J R Tighe
August 1991,
Journal of the American Society of Nephrology : JASN,
